TIS
Click for more information
0.00% 0.0¢ tissue therapies limited

ce mark, page-11

  1. resourced
    2,243 Posts.
    lightbulb Created with Sketch. 109
    clock Created with Sketch.
    12/06/12
    10:57
    Post #: 10292980
    I agree it is good to see TIS representing the only Australian Biotech company at the EUROPEAN LIFE SCIENCE CEO FORUM for PARTNERING & INVESTING....
    but why dont they bother telling shareholders and investors about this sort of thing?? We are actually part owners and it would be nice to know what our company is doing...

    Wonder whether the Notifying Body has asked its questions and whether we have responded yet... time will tell, I guess (coz TIS wont that's for sure).

    TIS Price at posting: 48.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

WGX Australian foreign investment regulators greenlight Westgold's buyout of Karora
right-arrow Created with Sketch.
1CG OneClick surpasses 150,000 registered users
right-arrow Created with Sketch.
FMG Andrew Forrest was seemingly possessed by the spirit of hydrogen – now he's cut 700 jobs and canned FFI
right-arrow Created with Sketch.
SKC SkyCity to lose NZ$5M in 2025 over complaint closedown
right-arrow Created with Sketch.
HIQ HITIQ's sensor-containing mouthguard OK'd by World Rugby specifications board
right-arrow Created with Sketch.
EVN Evolution shares up 3% on quarterly results for June showing rise in gold production
right-arrow Created with Sketch.
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.